In the battle against HIV and AIDS, a new warrior has emerged, but its acceptance as a friend in the fight has been slow.
Truvada is a drug that functions against HIV. It was approved in the early 2000s. It lowers virus production and slows disease progression in the patients who are infected. In the July 2012, Truvada got approval to treat Pre-exposure prophylaxis, or PrEP which made this drug beneficial as a preventive treatment for infection.
The U.S. Centers for Disease Control and Prevention (CDC) has recommended this drug to half a million people as the preventive HIV drug.
Even the health care providers have approved the drug as a preventive treatment but still people don't get the benefit. Even it is not embraced in the gay community as it should be.
Truvada use needs a HIV testing in the start along with the follow-up tests constantly after three months. Checking of HIV and STD infections and dug toxicity damages is highly necessary. Along with the high drug rate, the total cost of using this drug is around $13,000 per year. Gilead Sciences, Inc., the manufacturer of the drug, also offers medication assistance program for the people who are unable to afford it.
Preventive medications against HIV and AIDS could help to save many lives that are destroyed each year because of this disease, experts believe.
